Ole Nome

1.6k citations
39 papers · 1.2k indexed · h-index 19

Impact in

Papers in

Ole Nome

39 papers receiving 1.1k citations

Peers

Ole Nome
Comparison fields: 5 of 90
  • Pathology and Forensic Medicine 603
  • Genetics 273
  • Neurology 355
  • Oncology 317
  • Pulmonary and Respiratory Medicine 306
Replace Beate Klimm with:
Beate Klimm Germany
Yasser Khafaga Saudi Arabia
O Schweisguth France
E Damasio Italy
R. G. Hahn United States
P.N. Plowman United Kingdom
W. Paul Bowman United States
John Camoriano United States
Gail Jones United Kingdom
James Raschko United States
Ole Nome relative to Beate Klimm Germany Beate Klimm's profile →
Citations per field
00.5×1.6×
Beate Klimm · 1×
Citations per year

Countries citing papers authored by Ole Nome

Since Specialization
Citations

This map shows the geographic impact of Ole Nome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Nome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Nome more than expected).

Fields of papers citing papers by Ole Nome

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Nome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Nome. The network helps show where Ole Nome may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ole Nome, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ole Nome Line = papers co-authored together Ole Nome links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201918
2 200747
3 20067
4 2002189
5 199915
6 199634
7 199619
8 19963
9 199510
10 199547
11 199425
12 199426
13 1993131
14 199320
15 199214
16 19926
17 199211
18 1992109
19 199212
20 19919

About Ole Nome

Ole Nome is a scholar working on Genetics, Pathology and Forensic Medicine, Neurology, Pulmonary and Respiratory Medicine and Oncology, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), CNS Lymphoma Diagnosis and Treatment (9 papers), Glioma Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (7 papers), Brain Metastases and Treatment (6 papers), Medical Imaging Techniques and Applications (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (603 citations), Genetics (273 citations), Neurology (355 citations), Oncology (317 citations) and Pulmonary and Respiratory Medicine (306 citations). Ole Nome has collaborated with scholars based in Norway, India and Spain. Frequent co-authors include Stein Kvaløy, Harald Holte, A. F. Abrahamsen, Knut Lote, Einar Hannisdal, Henry Hirschberg, Kjell Watne, May Brit Lund, Jenny Foss Abrahamsen and Eva Skovlund. Their work appears in journals such as Acta Oncologica, Annals of Oncology, Journal of Neuro-Oncology, Neurosurgery and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026